Is Lantern Pharma (NASDAQ:LTRN) In A Good Position To Invest In Growth?

Yahoo Finance12/22 22:11

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga12/14 05:06

Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation From FDA For Treatment Of Triple Negative Breast Cancer

Benzinga12/03 21:12

Lantern Pharma & Starlight Therapeutics Present LP-184 (STAR-001) Phase 1b Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (SNO) 2024 Highlighting Novel Synthetic Lethality

Businesswire11/26 21:45

Lantern Pharma Inc. (LTRN) Q3 2024 Earnings Call Transcript

Earnings Call Transcripts11/09 08:23

Lantern Pharma 3Q Loss/Shr 42c >LTRN

Dow Jones11/08 06:37